Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.61
-0.20 (-1.52%)
Apr 29, 2026, 3:09 PM EDT - Market open
Korro Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 21.82 | 55.64 | 166.15 | 36.33 | 83.49 |
| Short-Term Investments | 53.33 | 70.45 | - | 18.92 | 35.04 |
| Cash & Short-Term Investments | 75.16 | 126.1 | 166.15 | 55.25 | 118.53 |
| Cash Growth | -40.40% | -24.11% | 200.74% | -53.39% | - |
| Receivables | 0.97 | 1.7 | - | - | - |
| Prepaid Expenses | 5.25 | 3.74 | 3.02 | 1.23 | 0.64 |
| Restricted Cash | 1 | - | 3.56 | 0.6 | 0.6 |
| Total Current Assets | 82.37 | 131.53 | 172.73 | 57.08 | 119.78 |
| Property, Plant & Equipment | 16.22 | 51.55 | 42.82 | 11.89 | 6.45 |
| Long-Term Investments | 10.03 | 36.96 | - | - | - |
| Other Long-Term Assets | 4.88 | 6.2 | 6.12 | 4.77 | 1.35 |
| Total Assets | 113.51 | 226.24 | 221.66 | 73.74 | 127.58 |
| Accounts Payable | 1.65 | 3.99 | 7.28 | 2.61 | 0.79 |
| Accrued Expenses | 7.61 | 6.17 | 9.82 | 3.18 | 3.22 |
| Current Portion of Leases | 2.67 | 1.28 | 1.99 | 2.92 | - |
| Current Unearned Revenue | - | 3.51 | - | - | - |
| Other Current Liabilities | - | - | 0.4 | - | 0.94 |
| Total Current Liabilities | 11.94 | 14.96 | 19.48 | 8.7 | 4.95 |
| Long-Term Leases | 40.81 | 43.48 | 31.22 | 0.21 | - |
| Long-Term Unearned Revenue | 7.84 | 5.91 | - | - | - |
| Other Long-Term Liabilities | 1.48 | 1.47 | 1.05 | - | 0.97 |
| Total Liabilities | 62.07 | 65.83 | 51.75 | 8.91 | 5.92 |
| Common Stock | 0.01 | 0.01 | 0.01 | - | 0.01 |
| Additional Paid-In Capital | 435.06 | 426.72 | 352.91 | 2.81 | 1.6 |
| Retained Earnings | -383.85 | -266.59 | -183.01 | -101.83 | -43.8 |
| Comprehensive Income & Other | 0.21 | 0.27 | - | -0.01 | -0.01 |
| Total Common Equity | 51.44 | 160.42 | 169.91 | -99.03 | -42.21 |
| Shareholders' Equity | 51.44 | 160.42 | 169.91 | 64.83 | 121.66 |
| Total Liabilities & Equity | 113.51 | 226.24 | 221.66 | 73.74 | 127.58 |
| Total Debt | 43.49 | 44.77 | 33.21 | 3.13 | - |
| Net Cash (Debt) | 41.7 | 118.29 | 132.94 | 52.12 | 118.53 |
| Net Cash Growth | -64.75% | -11.02% | 155.08% | -56.03% | - |
| Net Cash Per Share | 4.44 | 13.26 | 86.93 | 204.24 | 26.65 |
| Filing Date Shares Outstanding | 14.42 | 9.39 | 8.02 | 5.65 | 4.45 |
| Total Common Shares Outstanding | 9.42 | 9.38 | 8.02 | 5.4 | 4.45 |
| Working Capital | 70.44 | 116.57 | 153.25 | 48.38 | 114.83 |
| Book Value Per Share | 5.46 | 17.11 | 21.20 | -18.33 | -9.49 |
| Tangible Book Value | 51.44 | 160.42 | 169.91 | -99.03 | -42.21 |
| Tangible Book Value Per Share | 5.46 | 17.11 | 21.20 | -18.33 | -9.49 |
| Machinery | 9.05 | 12.49 | 11.91 | 9.13 | 4.68 |
| Construction In Progress | - | 0.11 | 8.24 | 2.05 | 0.63 |
| Leasehold Improvements | 9.68 | 22.44 | 3.36 | 2.94 | 2.88 |
Source: S&P Capital IQ. Standard template. Financial Sources.